lung disease News
-
Respiratory health AI trailblazer VIDA poised for increased scale with newest appointment to leadership team
VIDA Diagnostics, Inc. (“VIDA”), the leader in AI-powered lung imaging analysis, announced today that Todd Johnson has joined the company as chief technology officer. Johnson, a leader in enterprise imaging and advanced clinical applications, will apply his expertise to extend the breadth and depth of VIDA’s LungPrint solutions, ensuring the company’s AI (artificial ...
-
Pulmonx to Present at the Canaccord Genuity 42nd Annual Growth Conference
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Jul. 27, 2022-- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will present at the upcoming Canaccord Genuity 42nd Annual Growth Conference in Boston. Management is scheduled to present on Wednesday, August 10, 2022, at 1:00 PM PT / 4:00 PM ET. ...
-
Pulmonx to Present at the Bank of America Securities 2022 Healthcare Conference
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will present at the upcoming Bank of America Securities 2022 Healthcare Conference in Las Vegas. Management is scheduled to present on Tuesday, May 10, 2022, at 12:40 PM PT / 3:40 PM ET. A live and archived webcast of the presentation ...
-
Pulmonx to Present at the 34th Annual Piper Sandler Healthcare Conference
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside chat at the 34th Annual Piper Sandler Healthcare Conference in New York on Wednesday, November 30, 2022, at 11:30 AM PT / 2:30 PM ET. A live and archived webcast of the presentation will be available ...
-
Apollo Tyres Joins ‘Jan Andolan’ for TB-Free India
Apollo Tyres has joined the ‘Jan Andolan’ (Peoples’ Movement) for Tuberculosis (TB) Free India to contribute to India’s National TB Elimination Programme (NTEP) in order to meet the ambitious goal of eradication of TB from India by 2025, five years ahead of the Sustainable Development Goals programme (SDG 2030). Apollo Campaigns to Eradicate TB As part of this activity, ...
-
Pulmonx to Participate at Upcoming Investor Conferences
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in two upcoming investor conferences in New York. Pulmonx management is scheduled to participate in a fireside chat at the Stifel Healthcare Conference on Wednesday, November 16, 2022, at 8:00AM ET. Interested ...
-
VIDA Expands Global Footprint into Japan with Market Authorization Through Partner Clairvo
VIDA Diagnostics, Inc. (VIDA), the leader in lung and respiratory intelligence, has received market authorization in Japan for its VIDA Insights® software, paving the way for lung care teams to begin using the solution at the point of care. Clairvo Technologies, Inc., a wholly owned subsidiary of Marubeni Corporation, secured the certification from Japan’s Pharmaceuticals and Medical ...
-
Inversago Pharma presents data on INV-101 in Idiopathic Pulmonary Fibrosis at the ERS Congress 2022
Inversago Pharma Inc. (“Inversago”), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, announces the presentation of preclinical data at the 2022 Congress of the European Respiratory Society (ERS), currently held in Barcelona, Spain and online. These data show that Inversago’s INV-101 (zevaquenabant), a small molecule, peripherally-acting CB1 ...
-
2019 ATS/ERS Spirometry Standard - Now available on EasyOne Air, EasyOne Pro/LAB, and Easy on-PC
NDD Medical Technologies (NDD), a leading provider of diagnostic technology enabling healthcare professionals the early detection of COPD and other chronic lung diseases, has updated the entire EasyOne® product range, including the EasyOne Air, Easy on-PC, EasyOne Pro, and EasyOne Pro LAB, to be compliant with the ATS/ERS Standardization of Spirometry 2019. Spirometry is widely used in the ...
-
World’s Leading Lung Disease Experts Join NuMedii’s Idiopathic Pulmonary Fibrosis Advisory Board
MENLO PARK, Calif., January 8, 2018 – NuMedii, Inc. today announced the formation of an Idiopathic Pulmonary Fibrosis (IPF) Advisory Board consisting of the world’s leading experts in interstitial lung disease: Naftali Kaminski, MD; David A. Schwartz, MD; Kevin Brown, MD; Toby Maher, MD, PhD; Gisli Jenkins, MD, PhD; Zea Borok, MD; and, Paul Wolters, MD. The newly formed Board of ...
-
New mechanism of Elafin to prevent lung injury in mechanically ventilated newborns
tiakis BIOTECH AG today announced the publication of research results by Alcazar et al. from Stanford University on a new mechanism by which Elafin rescues lung cell survival in the lung of newborn mice subjected to mechanical ventilation. Neonatal chronic lung disease or bronchopulmonary dysplasia develops in preterm infants whose lungs are incompletely developed and therefore require ...
-
Coming soon: EPA’s 48-hour burn wise video contest
The U.S. Environmental Protection Agency is sponsoring a video contest for professional and amateur filmmakers on Burn Wise, the agency’s campaign to help citizens reduce pollution from their fireplaces and other wood-burning appliances. With the theme “Learn Before You Burn,” the winning 30- or 60-second videos will promote responsible wood-burning techniques that can help citizens save money ...
-
VIDA receives 510(k) clearance for deep learning-based enhancements to its LungPrint solution
VIDA Diagnostics, Inc. (“VIDA”), the leader in lung and respiratory intelligence, announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for enhancements to its LungPrint solution, including automated deep learning-based lung and lobe segmentation algorithms. This clearance further validates the quality and clinical efficacy of the ...
-
NuMedii Advances IPF Personalized Medicine with New Advisory Board to Guide AI Approach
NuMedii is advancing the field of personalized medicine for idiopathic pulmonary fibrosis (IPF) by creating a new advisory board that includes some of the world’s leading specialists in interstitial lung disease to guide a new approach to drug discovery based on artificial intelligence (AI). The California-based company has been exploring the potential of big data and AI since 2010 to ...
-
NuMedii Announces Creation of World’s First Single-Cell Sequencing Atlas for Idiopathic Pulmonary Fibrosis by its Collaborators
SAN MATEO, Calif., July 9, 2020 /PRNewswire/ — NuMedii, Inc., a data-driven drug discovery company, today announced the availability of the world’s first single-cell sequencing atlas for idiopathic pulmonary fibrosis (IPF) that was the result of a strategic research collaboration including the Yale School of Medicine, Baylor College of Medicine, Brigham and Women’s Hospital, and ...
-
OSF HealthCare advances innovative patient care using VIDA Insights
VIDA Diagnostics, Inc. (“VIDA”), the leader in lung and respiratory intelligence, today announced a new strategic partnership with Peoria, Illinois-OSF HealthCare that will make VIDA Insights available to care teams across the organization. VIDA and its comprehensive, lung intelligence solutions continue to gain traction among integrated delivery network (IDN) health care providers ...
-
Asian governments must address environmental problems to sustain long-term growth, says UN
Asia-Pacific is likely to continue to see strong economic growth this year, despite uncertainties posed by a slowing United States economy, according to a new United Nations report. “Key Economic Developments and Prospects in the Asia-Pacific Region 2008” – published by the UN Economic and Social Commission for Asia and the Pacific (ESCAP) – states that the region’s resilience will be underpinned ...
-
Nob Hill Therapeutics Selected as a Finalist for RESI Innovator’s Pitch Challenge
Nob Hill Therapeutics was selected as a finalist in the Redefining Early Stage Investments (RESI) Innovator’s Pitch Challenge (IPC). An opportunity for early-stage companies to gain exposure to conference attendees, pitch directly to a panel of relevant investors, and participate in a live Q&A session. The IPC focuses on early-stage life science companies actively raising capital and ...
-
EPA strengthens smog standard
The United States Environmental Protection Agency today proposed the strictest health standards to date for smog. Smog, also known as ground-level ozone, is linked to a number of serious health problems, ranging from aggravation of asthma to increased risk of premature death in people with heart or lung disease. Ozone can even harm healthy people who work and play outdoors. The agency is ...
-
Coala Life to go public on Nasdaq Stockholm to accelerate development efforts and market penetration
Stockholm, September 27, 2021: Coala Life, a leader in the field of cloud-based remote patient monitoring of heart and lung diseases, is moving towards a future as a listed company, through a so-called reverse IPO process via an acquisition by RNB Retail and Brands AB (“RNB”) listed on Nasdaq in Sweden. The news, which was presented today, opens up new interesting opportunities for an ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you